Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Minor system revision updating from v3.3.1 to v3.3.2, with no visible changes to study content, eligibility, or contact details.
    Difference
    0.2%
    Check dated 2025-12-01T16:55:21.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; the page now displays the new revision label and removes the previous one.
    Difference
    0.1%
    Check dated 2025-11-24T14:34:12.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The banner about the lapse in government funding and NIH operating status was removed.
    Difference
    0.4%
    Check dated 2025-11-17T06:54:43.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Core study details, eligibility criteria, and endpoints appear unchanged; only minor visual/layout adjustments were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-10T04:55:43.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The update shows minor UI/formatting adjustments and section reorganization without changes to the study's key details.
    Difference
    0.4%
    Check dated 2025-11-03T01:18:32.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    No significant changes detected. The page appears unchanged.
    Difference
    0.3%
    Check dated 2025-10-19T16:30:19.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.